Patient Safety & Product Quality

Patient safety and product quality have always been embedded in Indivior’s culture and are key elements of its patient-focused business model.

The management team views this aspect of the business as fundamental to the integrity of its day-to-day activities. Additionally, Indivior’s management promotes a culture of innovation and quality, which it believes is critical to maintaining patient trust. This culture enables workforce empowerment to foster and drive excellence.
 

Indivior has constructed and constantly evolves a robust pharmacovigilance management system. These processes monitor the safety of Indivior’s marketed and investigational products in a comprehensive and thorough manner. Indivior’s work in this area includes deploying an FDA-required Risk Evaluation and Mitigation Strategies (REMS) program to mitigate the risk of accidental overdose misuse and abuse of SUBOXONE Film, and to inform prescribers, pharmacists, and patients of the serious risks associated with SUBOXONE. Similarly, Indivior has and maintains an FDA-required REMS program for SUBLOCADE in the US to mitigate the risk of serious harm or death that could result from intravenous self-administration. Globally, risk management plans are being enhanced to minimize these risks in other countries.